RxDoctor Payments Data

Paul Cooper, MD

Foot and Ankle Surgery · Washington, DCNPI 1548269731

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $118,227 of the $186,332 with a category attached, or 63.4%. 16 manufacturers reported payments, led by Integra Lifesciences Corporation at 36.0% of the total. Reporting peaked in 2019 at $94,808 and has fallen 93.1% since, to $6,576 in 2025. Among foot and ankle surgery clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$186,332in general payments, 2019–2025

Across 151 payments — averaging $1233.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$67K
  • Stryker$56K
  • Smith+Nephew$49K
  • Oxford Performance Materials, Inc.$7K
  • Zimmer Biomet$2K
  • Medshape, Inc.$2K
  • plus $2K from 10 others
$172,000in research payments, 2019–2025

Across 3 payments — averaging $57,333 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smart-surgical Inc. Dba Burst Biologics$172K
$6,707in ownership & investment interests, 2019–2025

Across 2 payments — averaging $3353.43 each. An ownership or investment interest held by the physician or an immediate family member.

  • Oxford Performance Materials, Inc.$7K

What the payments were for

  • Royalty or licence$118,22763%
  • Consulting fees$61,37333%
  • Grants$1,0941%
  • Travel & lodging$1,5341%
  • Food & beverage$4,1042%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Integra Lifesciences Corporation9$67,020
Stryker79$56,468
Smith+Nephew20$49,294
Oxford Performance Materials, Inc.4$7,442
Zimmer Biomet12$2,276
Medshape, Inc.2$2,275
Ossio Inc4$452
Medtronic(2 entities)11$412
Linvatec Corporation3$348
Axogen1$137
Restor3d, Inc.1$74
Encore Medical, LP1$43
Embody, Inc.1$36
ERMI LLC1$21
Siemens Medical Solutions USA, Inc.1$18
Sanara Medtech Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$186,332 in reported general payments places this provider in the 95th percentile of 23 foot and ankle surgery providers in District of Columbia.

See all foot and ankle surgery providers in District of Columbia

Medicare billing

Part B allowed, 2024
$158,051
Medicare patients
226
Services billed
586

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other foot and ankle surgery in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →